In vitro Antitumour activity of orsellinates

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 65, Issue 1-2, 2010, Pages 43-48

  Bogo, Danielle ^a   de Fatima Cepa Matos, Maria ^a   Honda, Neli Kika ^a   Pontes, Elenir Curi ^a   Oguma, Patricia Midori ^a   da Silva Santos, Evelyn Cristina ^a   de Carvalho, João Ernesto ^b   Nomizo, Auro ^c  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytotoxic activity; Lecanoric acid; Orsellinates

Indexed keywords

ANTINEOPLASTIC AGENT; LECANORIC ACID; ORSELLINIC ACID; RESORCINOL DERIVATIVE; SALICYLIC ACID DERIVATIVE;

ANIMAL; ARTICLE; BREAST TUMOR; CELL ADHESION; CERCOPITHECUS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; EXPERIMENTAL MELANOMA; FEMALE; HISTORY; HUMAN; LIVER CELL CARCINOMA; TUMOR CELL LINE; VERO CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; FEMALE; HISTORY, MEDIEVAL; HUMANS; MELANOMA, EXPERIMENTAL; MODELS, MOLECULAR; RESORCINOLS; SALICYLATES; VERO CELLS;

EID: 77951633134     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2010-1-208     Document Type: Article

References (27)

1. Ahmann G. B. and Mathey A. (1967), Lecanoric acid and some constituents of Parmelia tinctorum and Pseudoevernia intense. Bryologist 70, 93-97.
2. Benz R. and McLaughlin S. (1983), The molecular mechanism of action of the proton ionophore FCCP (carbonylcyanide p-trifluoromethoxyphenylhydra-zone). Biophys. J. 41, 381-398.
3. Bézivin C., Tomasi F., Lohézic-Le Devehat F., and Boustie J. (2003), Cytotoxic activity of some lichen extracts on murine and human cancer cell lines. Phytomedicine 10, 499-503.
4. Cohen P. A., Hudson J. B., and Towers G. H. (1996), Antiviral activities of anthraquinones, bianthrones and hypericin derivatives from lichens. Experientia 52, 180-183.
5. Deliconstantinos G. (1987), Physiological aspects of membrane lipid fluidity in malignancy. Anticancer Res. 7,1011-1021.
6. Gomes A. T., Honda N. K., Roese F. M., Muzzi R. M., and Marques M. R. (2002), Bioactive derivatives obtained from lecanoric acid, a constituent of lichen Parmotrema tinctorum (Nyl.) Hale (Parmeliaceae). Rev. Bras. Farmacogn. 12, 74-75.
7. Gomes A. T., Honda N. K., Roese F. M., Muzzi R. M., and Sauer L. (2006), Cytotoxic activity of orsellinates. Z. Naturforsch. 61c, 653-657.
8. Hale M. E. (1983), The Biology of Lichens, 3rd ed. Edward Arnold, London.
9. Hansch C., McKarns S. C., Smith C. J., and Doolittle D. J. (2000), Comparative QSAR evidence for a free radical mechanism of phenol-induced toxicity. Chem. Biol. Interact. 127, 61-72.
10. Houghton P., Fang R., Techatanawat I., Steventon G., Hylands P. J., and Lee C. C. (2007), The sulphorhod-amine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity. Methods 42, 377-387.
11. Ingólfsdóttir K., Bloomfield S. F., and Hylands P. J. (1985), In vitro evaluation of the antimicrobial activity of lichen metabolites as potential preservatives. Antimicrob. Agents Chemother. 28, 289-292.
12. Kumar K. C. S. and Müller K. (1999), Lichen metabolites. 2. Antiproliferative and cytotoxic activity of gy-rophoric, usnic, and diffractaic acid on human kerati-nocyte growth. J. Nat. Prod. 62, 821-823.
13. Lopes T. I. B., Coelho R. G., Yoshida N. C., and Honda N. K. (2008), Radical-scavenging activity of orsellinates. Chem. Pharm. Bull. 56, 1551-1554.
14. Miyoshi H., Tsujishita H., Tokutake N., and Fujita T. (1990), Quantitative analysis of uncoupling activity of substituted phenols with a physicochemical sub-stituent and molecular parameters. Biochim. Biophys. Acta 1016, 99-106.
15. Nandi S., Vracko M., and Bagchi M. C. (2007), Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks. Chem. Biol. Drug Design 70, 424-436.
16. Nash T. H. (1996), In: Lichen Biology (Nash T. H., ed.). Cambridge University Press, Cambridge, pp. 1-7.
17. Neamati N., Hong H., Mazumder A., Wang S., Sunder S., Nicklaus M. C., Milne G. W. A., Proksa B., and Pommier Y. (1997), Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. J. Med. Chem. 40, 942-951.
18. Ögmundsdóttir H. M., Zoëga G. M., Gissurarson S. R., and Ingólfsdóttir K. (1998), Anti-proliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell-lines and mitogen-stimulated lymphocytes. J. Pharm. Pharmacol. 50, 107-115.
19. Schroeder F. (1984), Fluorescence probes in metastatic B16 melanoma membranes. Biochim. Biophys. Acta, Biomembranes 776, 299-312.
20. Selassie C. D., DeSoyza T. V., Rosario M., Gao H., and Hansch C. (1998), Phenol toxicity in leukemia cells: a radical process? Chem. Biol. Interact. 113, 175-190.
21. Selassie C. D., Kapur S., Verma R. P., and Rosario M. (2005), Cellular apoptosis and cytotoxicity of phenolic compounds: A quantitative structure-activity relationship study. J. Med. Chem. 48, 7234-7242.
22. Silverman R. B. (1992), The Organic Chemistry of Drug Design and Drug Action. Academic Press, San Diego.
23. Skehan P., Storeng R., Scudiero D., Monks A., McMa-hon J., Vistica D., Warren J. T., Bokesch H., Kenney S., and Boyd M. R. (1990), New colorimetric cyto-toxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107-1112.
24. Stich H. F. (1991), The beneficial and hazardous effects of simple phenolic compounds. Mutat. Res. 259, 307-324.
25. Thakur M., Agarwal A., Thakur A., and Khadikar P. V. (2004), QSAR study on phenolic activity: need of positive hydrophobic term (logP) in QSAR. Bioorg. Med. Chem. 12, 2287-2293.
26. Thompson D. C., Thompson J. A., Sugumaran M., and Moldeus P. (1993), Biological and toxicological consequences of quinone methide formation. Chem. Biol. Interact. 86, 129-162.
27. Von Hoff D. D., Forseth B., and Warfel L. E. (1985), Use of radiometric system to screen for antineoplas-tic agents: Correlation with a human tumor cloning system. Cancer Res. 45, 4032-4038.